1. Topical resiquimod dosing regimens in patients with multiple actinic keratoses: a multicentre, partly placebo‐controlled, double‐blind clinical trial. (1st February 2019) Authors: Stockfleth, E.; Hofbauer, G.F.L.; Reinhold, U.; Popp, G.; Hengge, U.R.; Szeimies, R.M.; Brüning, H.; Anliker, M.; Hunger, T.; Dummer, R.; Ulrich, C.; Kenzelmann, R.; Surber, C.; French, L.E. Journal: British journal of dermatology Issue: Volume 180:Number 2(2019) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Topical resiquimod dosing regimens in patients with multiple actinic keratoses: a multicentre, partly placebo‐controlled, double‐blind clinical trial. (22nd October 2018) Authors: Stockfleth, E.; Hofbauer, G.F.L.; Reinhold, U.; Popp, G.; Hengge, U.R.; Szeimies, R.M.; Brüning, H.; Anliker, M.; Hunger, T.; Dummer, R.; Ulrich, C.; Kenzelmann, R.; Surber, C.; French, L.E. Journal: British journal of dermatology Issue: Volume 180:Number 2(2019) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗